SciSparc Ltd. - Ordinary Shares (SPRC) analyst actions
Rating and price-target actions on SPRC in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the SPRC overview →
3 measured SPRC analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| SciSparc: NeuroThera Labs Announces Initiation of Phase IIb Clinical Trial at Hannover Medical School in Germany for Innovative Treatment of Tourette Syndrome | Press release | +0.92% | +13.16% | |
| SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder | Press release | +2.44% | -13.75% | |
| SciSparc and Clearmind Medicine Reflect on Successful Collaboration in 2023 Aiming to Upgrade Wide Range of Psychedelic-Based Treatments | Press release | -7.53% | -13.47% |
Keep exploring
More SPRC: earnings → · SEC filings → · SPRC overview →